Anti-AKT1+2+3 Polyclonal Antibody
應(yīng)用 WB
稀釋比例WB 1:3000.
交叉反應(yīng)Human Mouse Rat

產(chǎn)品型號：K106557P

更新時間：2022-08-15

廠商性質(zhì)：生產(chǎn)廠家

訪問量：1043

服務(wù)熱線

010-50973130

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

產(chǎn)品介紹

Anti-AKT1+2+3 Polyclonal Antibody

英文名稱	Anti-AKT1+2+3 Polyclonal Antibody
宿主	Rabbit
別名	AKT;CWS6;PKB;PKB-ALPHA;PRKBA;RAC;RAC-ALPHA
應(yīng)用	WB
稀釋比例	WB 1:3000.
交叉反應(yīng)	Human Mouse Rat
蛋白分子量	65kDa
Gene ID	207
保存	Store at -20°C. Avoid freeze / thaw cycles.
儲存液	Buffer: PBS with 0.03% Proclin300, 50% glycerol, pH7.3.
純化方法	Affinity purification
亞型	IgG
免疫原	A synthetic peptide of human AKT1+2+3
性狀	液體
Public Immunogen Range	A synthetic peptide of human AKT1+2+3
Subcellular Locations	Cell membrane Cytoplasm Nucleus
Swiss Prot	P31749
克隆類型	Polyclonal Antibody
背景資料	The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Mutations in this gene have been associated with the Proteus syndrome. Multiple alternatively spliced transcript variants have been found for this gene.